Neoplasia yield and colonoscopic workload of surveillance regimes for colorectal cancer in colitis patients: A retrospective study comparing the performance of the updated AGA and BSG guidelines

Inflammatory Bowel Diseases

Volumn 19, Issue 12, 2013, Pages 2603-2610

  Mooiweer, Erik ^a   Van Der Meulen, Andrea E ^b   Van Bodegraven, Adriaan A ^c   Jansen, Jeroen M ^d   Mahmmod, Nofel ^e   Nijsten, Joyce ^a   Van Oijen, Martijn G H ^a   Siersema, Peter D ^a   Oldenburg, Bas ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d OLVG Amsterdam ^*  (Netherlands)

^e ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Colorectal cancer; Guidelines; Inflammatory bowel disease; Surveillance

Indexed keywords

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CHROMOENDOSCOPY; COLON BIOPSY; COLON RESECTION; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CROHN DISEASE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE DURATION; FAMILY HISTORY; FEMALE; FOLLOW UP; GASTROINTESTINAL DYSPLASIA; HIGH GRADE COLORECTAL DYSPLASIA; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; ULCERATIVE COLITIS; WORKLOAD;

COLITIS, ULCERATIVE; COLONOSCOPY; COLORECTAL NEOPLASMS; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; GASTROENTEROLOGY; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PRACTICE GUIDELINES AS TOPIC; PRECANCEROUS CONDITIONS; PROGNOSIS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TIME FACTORS; WORKLOAD;

EID: 84888351059     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e3182a74b27     Document Type: Article

References (22)

1. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526-535.
2. Mpofu C, Watson AJ, Rhodes JM. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev. 2004;CD000279.
3. Cairns S, Scholefield JH. Guidelines for colorectal cancer screening in high risk groups. Gut. 2002;51(suppl 5):V1-V2.
4. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale - update based on new evidence. Gastroenterology. 2003;124:544-560.
5. Gillen CD, Walmsley RS, Prior P, et al. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut. 1994;35:1590-1592.
6. Farraye FA, Odze RD, Eaden J, et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:738-745.
7. Cairns SR, Scholefield JH, Steele RJ, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59:666-689.
8. Enthoven AC, van de Ven WP. Going Dutch - managed-competition health insurance in the Netherlands. N Engl J Med. 2007;357: 2421-2423.
9. Elsadani NN, East JE, Walters JR. New 2010 British Society of Gastroenterology colitis surveillance guidelines: costs and surveillance intervals. Gut. 2011;60:282-283.
10. Claessen MM, Vleggaar FP, Tytgat KM, et al. High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol. 2009;50:158-164.
11. Soetikno RM, Lin OS, Heidenreich PA, et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc. 2002;56:48-54.
12. Askling J, Dickman PW, Karlen P, et al. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study. Lancet. 2001;357:262-266.
13. Nuako KW, Ahlquist DA, Mahoney DW, et al. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. Gastroenterology. 1998;115:1079-1083.
14. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451-459.
15. Jess T, Loftus EV Jr, Velayos FS, et al. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota. Am J Gastroenterol. 2007;102:829-836.
16. Gupta RB, Harpaz N, Itzkowitz S, et al. Histological inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. 2007;133:1099-1105.
17. Rutter MD, Saunders BP, Wilkinson KH, et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut. 2004;53:1813-1816.
18. Gumaste V, Sachar DB, Greenstein AJ. Benign and malignant colorectal strictures in ulcerative colitis. Gut. 1992;33:938-941.
19. Reiser JR, Waye JD, Janowitz HD, et al. Adenocarcinoma in strictures of ulcerative colitis without antecedent dysplasia by colonoscopy. Am J Gastroenterol. 1994;89:119-122.
20. van Schaik FD, ten Kate FJ, Offerhaus GJ, et al. Misclassification of dysplasia in patients with inflammatory bowel disease: consequences for progression rates to advanced neoplasia. Inflamm Bowel Dis. 2011;17: 1108-1116.
21. Rutter MD, Saunders BP, Schofield G, et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut. 2004; 53:256-260.
22. Velayos FS, Loftus EV Jr, Jess T, et al. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-control study. Gastroenterology. 2006;130:1941-1949.